Breast cancer researcher and Komen grantee Dr. Zachary Hartman is pioneering a groundbreaking clinical trial at Duke Cancer Center to test the effectiveness of a vaccine he hopes will improve outcomes for people living with HER2-positive metastatic breast cancer (MBC), including his mother.
Komen-funded researcher Dr. Amelie Ramirez is seeking to improve long-term outcomes for Hispanic and Latina breast cancer survivors through a holistic program.
Komen-funded researcher Dr. Pedram Ravazi is leading a three-part study to identify microscopic breast cancer metastases in patients so it can be treated before it becomes deadly.
Dr. Elizabeth Mittendorf is a Komen grantee and is working to use the immune system to kill breast cancer and prevent its return.
Dr. Nikhil Wagle is a Komen grantee and is using genomics to better understand why some patients respond to treatment and others do not.
Dr. Neil Vasan is a Komen grantee and recounts some amazing opportunities and discoveries during the COIVD-19 pandemic.
Susan G. Komen has been deeply invested in supporting researchers at Massachusetts cancer institutions since its founding in 1982. Over the last forty years, Komen has awarded 260 grants, totaling $88 million in research, locally. Ann Partridge, M.D., M.P.H., has dedicated her career to understanding and treating breast cancer in young women. She is also […]
Susan G. Komen has been deeply invested in supporting researchers at New York cancer institutions since its founding in 1982. Over the last forty years, Komen has awarded 209 grants, totaling $58.4 million in research, locally. Rulla Tamimi, Sc.D, professor of population health sciences at Weill Cornell Medicine, is a Susan G. Komen grantee. She […]
For Komen Scholar Alana Welm, Ph.D., researching metastatic breast cancer (MBC) is the greatest unmet medical need in breast cancer treatment today.
Inflammatory breast cancer – or IBC – is an aggressive subtype of breast cancer that often presents as a breast rash, and not a lump. It progresses rapidly and is often misdiagnosed, or diagnosis is delayed, resulting in more later-stage cases when prognosis is poorer. Susan G. Komen is awarding a $350,000 grant to Dr. […]
Christina Curtis, Ph.D., M.S., is studying the information inside breast cancer tumors in patients at highest risk of relapse, or recurrence, to better understand which therapies will work best to treat the cancer and prevent recurrence. Curtis was named a Komen Scholar in 2020 – an advisory group of distinguished leaders in breast cancer research, […]
Susan G. Komen has been leading a group of patient advocates, clinicians and researchers to advance our understanding of inflammatory breast cancer.